GENEPEUTIC BIO CO., LTD.
The First GMP-Compliant Cell and Gene Therapy
Manufacturing Facility in Thailand.
Genepeutic Bio was founded in 2020 to deliver the next wave of personalized cell and gene therapy for patients in Asia, initiating with Chimeric antigen receptor (CAR) T-cells.
Genepeutic Bio is a contract development and manufacturing organization (CDMO) providing services for CAR T-cells production. Under a GMP-compliant facility, which meets the international standard, we ensure the quality of our products and services for patient’s safety.
The First GMP-Compliant for Cell and Gene Therapy in Thailand
The facility complies with the international standards utilizing the lastest technology of CAR-T to fight cancer but ensure patient’s safety through extensive list of quality release testings.
CELL AND GENE THERAPY
This technology, classified as advanced therapy medicinal products (ATMPs), utilizes the body’s own immune cells, T-cells, that undergoes gene modification to treat the deliberating diseases such as cancers.